<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6222480</article-id><article-id pub-id-type="doi">10.3390/molecules23081897</article-id><article-id pub-id-type="publisher-id">molecules-23-01897</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Environmentally Friendly Approach to Knoevenagel Condensation of Rhodanine in Choline Chloride: Urea Deep Eutectic Solvent and QSAR Studies on Their Antioxidant Activity </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Molnar</surname><given-names>Maja</given-names></name><xref ref-type="aff" rid="af1-molecules-23-01897">1</xref><xref rid="c1-molecules-23-01897" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Brahmbhatt</surname><given-names>Harshad</given-names></name><xref ref-type="aff" rid="af1-molecules-23-01897">1</xref></contrib><contrib contrib-type="author"><name><surname>Rastija</surname><given-names>Vesna</given-names></name><xref ref-type="aff" rid="af2-molecules-23-01897">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5369-1755</contrib-id><name><surname>Pavić</surname><given-names>Valentina</given-names></name><xref ref-type="aff" rid="af3-molecules-23-01897">3</xref></contrib><contrib contrib-type="author"><name><surname>Komar</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="af1-molecules-23-01897">1</xref></contrib><contrib contrib-type="author"><name><surname>Karnaš</surname><given-names>Maja</given-names></name><xref ref-type="aff" rid="af2-molecules-23-01897">2</xref></contrib><contrib contrib-type="author"><name><surname>Babić</surname><given-names>Jurislav</given-names></name><xref ref-type="aff" rid="af1-molecules-23-01897">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Sabatier</surname><given-names>Jean-Marc</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-23-01897"><label>1</label>Faculty of Food Technology Osijek, Josip Juraj Strossmayer University of Osijek, Franje Kuhaca 20, 31000 Osijek, Croatia; <email>brahmbhattharshad@hotmail.com</email> (H.B.); <email>mkomar@ptfos.hr</email> (M.K.); <email>jbabic@ptfos.hr</email> (J.B.)</aff><aff id="af2-molecules-23-01897"><label>2</label>Faculty of Agriculture, Josip Juraj Strossmayer University of Osijek, Vladimira Preloga 1, 31000 Osijek, Croatia; <email>Vesna.Rastija@pfos.hr</email> (V.R.); <email>Maja.Karnas@pfos.hr</email> (M.K.)</aff><aff id="af3-molecules-23-01897"><label>3</label>Department of Biology, Josip Juraj Strossmayer University of Osijek, Cara Hadrijana 8/A, 31000 Osijek, Croatia; <email>vpavic@biologija.unios.hr</email></aff><author-notes><corresp id="c1-molecules-23-01897"><label>*</label>Correspondence: <email>maja.molnar@ptfos.hr</email>; Tel.: +385-31-224-342</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2018</year></pub-date><volume>23</volume><issue>8</issue><elocation-id>1897</elocation-id><history><date date-type="received"><day>27</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>© 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>A series of rhodanine derivatives was synthesized in the Knoevenagel condensation of rhodanine and different aldehydes using choline chloride:urea (1:2) deep eutectic solvent. </plain></SENT>
<SENT sid="2" pm="."><plain>This environmentally friendly and catalyst free approach was very effective in the condensation of rhodanine with commercially available aldehydes, as well as the ones synthesized in our laboratory. </plain></SENT>
<SENT sid="3" pm="."><plain>All rhodanine derivatives were subjected to 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) scavenging activity investigation and quantitative structure-activity relationship (QSAR) studies were performed to elucidate their structure-activity relationship. </plain></SENT>
<SENT sid="4" pm="."><plain>The best multiple linear QSAR model demonstrate a stability in the internal validation and Y-randomization (R2 = 0.81; F = 24.225; Q2loo = 0.72; R2Yscr = 0.148). </plain></SENT>
<SENT sid="5" pm="."><plain>Sphericity of the molecule, ratio of symmetric atoms enhanced atomic mass along the principle axes in regard to total number of atoms in molecule, and 3D distribution of the atoms higher electronegativity (O, N, and S) in molecules are important characteristic for antioxidant ability of rhodanine derivatives. </plain></SENT>
<SENT sid="6" pm="."><plain>Molecular docking studies were carried out in order to explain in silico antioxidant studies, a specific protein tyrosine kinase (2HCK). </plain></SENT>
<SENT sid="7" pm="."><plain>The binding interactions of the most active compound have shown strong hydrogen bonding and van der Waals interactions with the target protein. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>rhodanine</kwd><kwd>deep eutectic solvents</kwd><kwd>Knoevenagel condensation</kwd><kwd>antioxidant activity</kwd><kwd>QSAR</kwd><kwd>molecular docking</kwd><kwd>tyrosinase</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec id="sec1-molecules-23-01897"><title><text><SENT sid="8" pm="."><plain>1. </plain></SENT>
<SENT sid="9" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="10" pm="."><plain>Deep eutectic solvents (DESs) are often characterized as environmentally friendly and acceptable, due to their low vapor pressure, non-toxic properties, reusability, and cheapness [1,2]. </plain></SENT>
<SENT sid="11" pm="."><plain>DESs are formed by the interaction of different hydrogen bond acceptors (HBA), like quaternary ammonium salts, and hydrogen bond donors (HBD), like urea, carboxylic acids, sugars or amides [1]. </plain></SENT>
<SENT sid="12" pm="."><plain>They have been proven to be efficient in many applications, such as organic synthesis, extraction, electrochemistry, etc. </plain></SENT>
<SENT sid="13" pm="."><plain>[3,4,5]. </plain></SENT>
<SENT sid="14" pm="."><plain>Their application in organic synthesis includes synthesis of different heterocycles [6,7,8,9,10], esterification [11], aldol reactions [12], halogenation [13] as well as N-acetylation of amines [14], synthesis of mercapto quinazolinones [15], and Schiff bases [16], all performed by our group. </plain></SENT>
<SENT sid="15" pm="."><plain>Knoevenagel condensation in deep eutectic solvents has been studied by Keshavarzipour and Tavakol [17], indicating that DESs could be a very useful tool in this type of condensation. </plain></SENT>
<SENT sid="16" pm="."><plain>Knoevenagel condensation has been employed in the synthesis of numerous heterocyclic compounds, and is one of the basic reactions in organic chemistry. </plain></SENT>
<SENT sid="17" pm="."><plain>Many different conditions, catalysts and solvent were studied in this regard. </plain></SENT>
<SENT sid="18" pm="."><plain>Yarovenko et al. [18] studied Knoevenagel condensation of rhodanine with various aldehydes in different solvents and with different catalysts. </plain></SENT>
<SENT sid="19" pm="."><plain>They found that methanol as a solvent and ethylenediammonium diacetate at ambient temperature gave high yield of the product, sodium acetate in acetic acid or acetic anhydride gave moderate yields, while ethanol and piperidine as a catalyst gave no product. </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>N-Substituted 5-arylidenerhodanines are usually synthesized by the Knoevenagel condensation of the N-substituted rhodanine with various aldehydes, conventionally or using microwaves in one-pot two-step process [19]. </plain></SENT>
<SENT sid="21" pm="."><plain>Nitche and Klein synthesized N-substituted rhodanines from amines under microwaves using water as a solvent [20], while Azizi et al. synthesized arylidene rhodanine derivatives by condensation of primary amines, aldehydes, ethyl chloroacetate, and carbon disulphide in polyethylene glycol (PEG) at room temperature or with ultrasonic irradiation [21]. </plain></SENT>
<SENT sid="22" pm="."><plain>Suresh and Sandhu performed the Knoevenagel condensation of rhodanines using ionic liquids under ultrasound irradiation [22]. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Rhodanines have been reported to possess antibacterial [23], antiviral [24], antimalarial [25], antifungal [26], and antitumor activity [27]. </plain></SENT>
<SENT sid="24" pm="."><plain>Antioxidants are the bioactive chemical compounds which fight against oxidative stress by neutralizing the free radicals, such as reactive oxygen species (ROS) and thereby prevent many diseases. </plain></SENT>
<SENT sid="25" pm="."><plain>Excessive generation of the reactive oxygen species has been shown to activate protein kinases. </plain></SENT>
<SENT sid="26" pm="."><plain>The small molecules may function through directly inhibiting the catalytic activity of the kinase by interfering with the binding of adenosine triphosphate (ATP) or substrates [28]. </plain></SENT>
</text></p><p><text><SENT sid="27" pm="."><plain>Therefore, the aim of this research is to employ a novel green approach in Knoevenagel condensation of rhodanine derivatives as potential antioxidants. </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>Furthermore, in order to signify the importance of structural and chemical attributes for the antioxidant activity of 5-arylidenerhodanines, and to improve further research on the mechanisms of action of these compounds against ROS, quantitative structure-activity relationship (QSAR) analysis is performed. </plain></SENT>
<SENT sid="29" pm="."><plain>Interaction of 5-arylidenerhodanines and haematopoietic cell tyrosine kinase (Hck) in silico has evaluated by molecular docking based on binding mode of quercetin as inhibitor. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS,DISCUSS"><sec id="sec2-molecules-23-01897"><title><text><SENT sid="30" pm="."><plain>2. </plain></SENT>
<SENT sid="31" pm="."><plain>Results and Discussion </plain></SENT>
</text></title><sec id="sec2dot1-molecules-23-01897"><title><text><SENT sid="32" pm="."><plain>2.1. </plain></SENT>
<SENT sid="33" pm="."><plain>Synthesis </plain></SENT>
</text></title><p><text><SENT sid="34" pm="."><plain>Synthesis of the target compounds (Scheme 1) was performed from rhodanine and corresponding aldehydes, commercially available and synthesized ones, as the starting compounds. </plain></SENT>
<SENT sid="35" pm="."><plain>The deep eutectic solvent formed of the choline chloride and urea was found to be very suitable for this type of condensation, since no catalyst was required, and the yields of the compounds were moderate to excellent. </plain></SENT>
<SENT sid="36" pm="."><plain>Besides its green character, this method is characterized by a simplicity of post synthetic procedures, which includes the addition of water into reaction mixture followed by product precipitation. </plain></SENT>
<SENT sid="37" pm="."><plain>A formation of the condensed rhodanine derivatives was confirmed by nuclear magnetic resonance (NMR) spectroscopy, where there is no rhodanine –CH2– peak around 4.2 ppm noticed in synthesized compounds. </plain></SENT>
<SENT sid="38" pm="."><plain>Furthermore, new peaks appear in the synthesized compounds and are attributed to aromatic protons of the substituents 7.07–7.50 ppm, as well as =CH– proton around 7.7 ppm. </plain></SENT>
<SENT sid="39" pm="."><plain>Unsubstituted –NH rhodanine group in the compounds 2a–k is characterized by the peak around 13.55 ppm. </plain></SENT>
</text></p><p><text><SENT sid="40" pm="."><plain>We have also investigated a possibility to recycle and reuse DES in several cycles for the same reaction. </plain></SENT>
<SENT sid="41" pm="."><plain>As a model reaction we utilized a reaction between rhodanine and 4-dimethylaminobenzaldehyde. </plain></SENT>
<SENT sid="42" pm="."><plain>After the isolation of desired product, water was evaporated from DES and the same DES was used again for the same reaction. </plain></SENT>
<SENT sid="43" pm="."><plain>We performed three cycles of the above described procedure and the results are presented in Table 1. </plain></SENT>
<SENT sid="44" pm="."><plain>These results confirmed the fact stated before, that DESs, besides other characteristics, owe their green character to the fact that they can be effectively reused. </plain></SENT>
</text></p></sec><sec id="sec2dot2-molecules-23-01897"><title><text><SENT sid="45" pm="."><plain>2.2. </plain></SENT>
<SENT sid="46" pm="."><plain>Antioxidant Activity </plain></SENT>
</text></title><p><text><SENT sid="47" pm="."><plain>Compounds (2a–3f) were investigated for their antioxidant activity expressed as % 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) scavenging activity. </plain></SENT>
<SENT sid="48" pm="."><plain>Data presented in Table 2 show that the substituents on 5-arylidenerhodanines have a great influence on the antioxidant activity. </plain></SENT>
<SENT sid="49" pm="."><plain>Benzylidene derivatives of the 5-arylidenerhodanines (2a–2o) manifested enhanced antioxidant activity, compared to 1,3-diphenyl-1H-pyrazole derivatives (3a–3f). </plain></SENT>
<SENT sid="50" pm="."><plain>Benzylidene derivative 2e, with two hydroxyl groups in 3,4-postion on phenyl ring, showed the highest antioxidant activity of 71.2%. </plain></SENT>
<SENT sid="51" pm="."><plain>Substitution of the 3-OH group with methoxy group decreased the activity of compound 2f (39.2%). </plain></SENT>
<SENT sid="52" pm="."><plain>Furthermore, when a starting rhodanine compounds 1–3 are compared to the substituted ones, it is noticeable that the substitution of rhodanine 1 in position 5 (compounds 2a–k) enhances an antioxidant activity in most cases. </plain></SENT>
<SENT sid="53" pm="."><plain>For derivatives (2l–o) of compound 2, as well as compounds 3a–f, derivatives of compound 3, it is noticed that substitution of a starting compounds in position 5 decreases the antioxidant activity. </plain></SENT>
</text></p></sec><sec id="sec2dot3-molecules-23-01897"><title><text><SENT sid="54" pm="."><plain>2.3. </plain></SENT>
<SENT sid="55" pm="."><plain>QSAR Models </plain></SENT>
</text></title><p><text><SENT sid="56" pm="."><plain>The best QSAR model for the antioxidant activity of 21 rhodanine derivatives was obtained by the combination of DRAGON and ADMEWORKS descriptors:log % DPPH = 18.086 − 9.117 SPH − 5.494 Mor24e − 44.94 G2m(1) where SPH is a sphericity of molecule; Mor24e is 3D-MoRSE descriptor reflects the contribution of the 3D distribution of Sanderson electronegativity; and G2m is the 2nd component symmetry directional WHIM index. </plain></SENT>
</text></p><p><text><SENT sid="57" pm="."><plain>Fitting criteria:R2 = 0.81; R2adj = 0.777; Kxx = 0.264; ΔK = 0.05; RMSEtr = 0.342; MAEtr = 0.277; RSStr = 2.46; CCCtr = 0.895; s = 0.38; F = 24.225 </plain></SENT>
</text></p><p><text><SENT sid="58" pm="."><plain>Internal validation criteria:Q2loo = 0.72; RMSEcv = 0.416; MAEcv = 0.348; CCCcv = 0.843; PRESScv = 3.629 </plain></SENT>
</text></p><p><text><SENT sid="59" pm="."><plain>Robustness:R2Yscr = 0.148; Q2Yscr = −0.351; RMSEAVYscr = 0.724 </plain></SENT>
</text></p><p><text><SENT sid="60" pm="."><plain>Descriptor values, experimental values and values of the antioxidant activity calculated by model, as leverage of compounds (HAT values) are given in Supplementary Material 1 (SM 1). </plain></SENT>
</text></p><p><text><SENT sid="61" pm="."><plain>The model satisfied fitting and internal validation criteria: R2 ≥ 0.60 (the closer R2 values are to unity, the more similar calculated values are to the experimental ones); CCC ≥ 0.85; RMSE and MAE close to zero and RMSEtr &lt; RMSEcv (Table 3). </plain></SENT>
<SENT sid="62" pm="."><plain>Also, larger F statistic and lower standard deviation means that the model is more significant. </plain></SENT>
<SENT sid="63" pm="."><plain>Robustness of obtained QSAR models is affirmed by R2yscr and Q2yscr values &lt; 0.2, as R2yscr &gt; Q2yscr [29]. </plain></SENT>
<SENT sid="64" pm="."><plain>Low collinearity between descriptors included in models is verified by the low values of Kxx and values of ΔK ≥ 0.05. </plain></SENT>
<SENT sid="65" pm="."><plain>Williams plots for the same models reveal no outliers, but compound 2o, which is practically inactive (% DPPH = 0.1), is outside of applicability domain (Figure 1). </plain></SENT>
<SENT sid="66" pm="."><plain>Its leverage (HAT = 0.583) is greater than the warning leverage (h* = 0.571), therefore predicted value of compound 2o must be used with a great care. </plain></SENT>
<SENT sid="67" pm="."><plain>A scatter plot of the experimentally obtained antioxidant activity by the model (1) is shown in Figure 2. </plain></SENT>
</text></p><p><text><SENT sid="68" pm="."><plain>Due to a small number of molecules in the dataset it was not possible to make an external validation. </plain></SENT>
<SENT sid="69" pm="."><plain>Despite the fact that the model is not predictive, included molecular descriptors may relieve in elucidation of the important physicochemical and structural requirements for the antioxidant activity of rhodanine derivatives. </plain></SENT>
<SENT sid="70" pm="."><plain>Sphericity (SPH) is a geometrical descriptor. </plain></SENT>
<SENT sid="71" pm="."><plain>The sphericity index varies from zero for flat molecules, to unity for totally spherical molecules [30]. </plain></SENT>
<SENT sid="72" pm="."><plain>According to the negative coefficient of SPH in Equation (1), the more spherical the molecule, the higher is the value for this descriptor, which results in a higher antioxidant ability. </plain></SENT>
<SENT sid="73" pm="."><plain>The 3D-MoRSE (Molecular Representation of Structures based on Electronic diffraction) descriptor Mor24e reflects the contribution of 3D distribution of Sanderson electronegativity (e) at a scattering parameter s = 23 Å−1 [31]. </plain></SENT>
<SENT sid="74" pm="."><plain>According to the model (1), it is expected that the increased values of Mor24e indicate the higher antioxidant activity. </plain></SENT>
<SENT sid="75" pm="."><plain>This descriptor is extremely sensitive to the position of the atoms of higher electronegativity (O, N, and S) in molecules. </plain></SENT>
<SENT sid="76" pm="."><plain>According to the negative coefficients of Mor24e in Equation (1), compounds with the higher antioxidant activity have enhanced positive values of this descriptor. </plain></SENT>
</text></p><p><text><SENT sid="77" pm="."><plain>The third variable in the model (1) is WHIM descriptors (Weighted Holistic Invariant Molecular descriptors) G2m (2nd component symmetry directional WHIM index/weighted by mass). </plain></SENT>
<SENT sid="78" pm="."><plain>WHIM descriptors (Weighted Holistic Invariant Molecular descriptors) are geometrical descriptors based on the statistical indices, calculated on the projections of the atoms along principal axes [32]. G2m captures the 3D information about symmetry along the principal axes. </plain></SENT>
<SENT sid="79" pm="."><plain>Molecular symmetry is evaluated on the basis of the number of symmetric atoms with respect to the molecule centre, and the number of unsymmetrical atoms. </plain></SENT>
<SENT sid="80" pm="."><plain>Considering the negative coefficient of G2m in Equation (1), it may be concluded that molecules with symmetrical distribution of atoms higher atomic mass along the second axes have better antioxidant ability. </plain></SENT>
<SENT sid="81" pm="."><plain>Benzylidene derivatives of 5-arylidenerhodanines (2a–2o) have a smaller total number of atoms and more symmetrical molecular shape compared to the 1,3-diphenyl-1H-pyrazole derivatives (3a–3f). </plain></SENT>
<SENT sid="82" pm="."><plain>Consequently, benzylidene derivatives (2a–2o) have higher values of G2m and the increased antioxidant activity (SM 1). </plain></SENT>
</text></p></sec><sec id="sec2dot4-molecules-23-01897"><title><text><SENT sid="83" pm="."><plain>2.4. </plain></SENT>
<SENT sid="84" pm="."><plain>Molecular Docking Study </plain></SENT>
</text></title><p><text><SENT sid="85" pm="."><plain>Molecular docking studies provide a virtual screening of different molecules as a potential ligands to predict their ability to interact with the given target candidates. </plain></SENT>
<SENT sid="86" pm="."><plain>For the present study we have chosen the hematopoietic cell tyrosine kinase (PDB ID: 2HCK) in the complex with quercetin as a target molecule [33]. </plain></SENT>
<SENT sid="87" pm="."><plain>Molecule with the best determined antioxidant activity (2e) was chosen as a ligand. </plain></SENT>
<SENT sid="88" pm="."><plain>Docking score and energy of the interactions between protein residue and ligand are tabulated in Table 3. </plain></SENT>
</text></p><p><text><SENT sid="89" pm="."><plain>Figure 3 illustrates the interaction of compound 2e with 2HCK in binding site, while Figure 4 shows the cavity of hematopoietic cell tyrosine kinase with the docked compound 2e. </plain></SENT>
<SENT sid="90" pm="."><plain>M and S indicate the main chain and the side chain of the interacting residue, respectively. </plain></SENT>
</text></p><p><text><SENT sid="91" pm="."><plain>Molecular docking confirmed that the (Z)-5-(3,4-dihydroxybenzylidene)-2-thioxothiazolidin-4-one (2e) forms the key interactions, the four H bond with Met 341, Ser 345 (one with the main chain, and the other one with the side chain), and with Asp 348. </plain></SENT>
<SENT sid="92" pm="."><plain>Compound 2e forms the van der Waals interactions with Leu 273, Val 281, Phe 340, Gly 344, Ser 345, and Leu 393. </plain></SENT>
<SENT sid="93" pm="."><plain>Interactions of the molecule 2e match with the interactions of quercetin in the binding site. </plain></SENT>
<SENT sid="94" pm="."><plain>Quercetin forms H bonds with Val 281, Leu 273, Gly 344, Leu 393, Met 341, and Ser 345 located at the C-terminal lobe of tyrosine kinase Hck [33]. </plain></SENT>
<SENT sid="95" pm="."><plain>The hematopoietic cell kinase (Hck) is a member of the tyrosine-protein kinase (SRC) family of the cytoplasmic tyrosine kinases (SFKs), and is expressed in the cells of the myeloid and B-lymphocyte cell lineages. </plain></SENT>
<SENT sid="96" pm="."><plain>Excessive HcK activation is associated with several types of leukemia, and enhances the cell proliferation [34]. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="METHODS"><sec id="sec3-molecules-23-01897"><title><text><SENT sid="97" pm="."><plain>3. </plain></SENT>
<SENT sid="98" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="sec3dot1-molecules-23-01897"><title><text><SENT sid="99" pm="."><plain>3.1. </plain></SENT>
<SENT sid="100" pm="."><plain>General </plain></SENT>
</text></title><p><text><SENT sid="101" pm="."><plain>All chemicals were purchased from the commercial suppliers. </plain></SENT>
<SENT sid="102" pm="."><plain>Melting points of all compounds were determined with the Electrotermal (Rochford, UK) melting point apparatus and were used without correction. </plain></SENT>
<SENT sid="103" pm="."><plain>Thin layer chromatography (TLC) was performed in benzene:acetone:acetic acid (8:1:1) as a solvent, with the fluorescent silica gel plates HF254 (Merck, Darmstadt, Germany). 1H and 13C-NMR spectra were recorded on the Bruker Avance 600 MHz NMR Spectrometer (Bruker Biospin GmbH, Rheinstetten, Germany) at 293 K with DMSO-d6 was as a solvent and tetramethylsilane (TMS) as an internal standard. </plain></SENT>
<SENT sid="104" pm="."><plain>The mass spectra were recorded by the LC/MS/MS API 2000 (Applied Biosystems/MDS SCIEX, Redwood City, CA, USA). </plain></SENT>
<SENT sid="105" pm="."><plain>Absorbance for antioxidant activity was measured with Helious ϒ, UV-Vis spectrophotometer (Thermo spectronic, Waltham, MA, USA). </plain></SENT>
</text></p></sec><sec id="sec3dot2-molecules-23-01897"><title><text><SENT sid="106" pm="."><plain>3.2. </plain></SENT>
<SENT sid="107" pm="."><plain>DES Preparation </plain></SENT>
</text></title><p><text><SENT sid="108" pm="."><plain>DES was prepared as described by Amić and Molnar [14]. </plain></SENT>
<SENT sid="109" pm="."><plain>Briefly, choline chloride and urea (molar ratio 1:2) were stirred at 80 °C until the clear liquid was formed. </plain></SENT>
<SENT sid="110" pm="."><plain>DES was cooled to room temperature and used as such in further synthesis of the rhodanine compounds. </plain></SENT>
</text></p></sec><sec id="sec3dot3-molecules-23-01897"><title><text><SENT sid="111" pm="."><plain>3.3. </plain></SENT>
<SENT sid="112" pm="."><plain>Knoevenagel Condensation in Choline Chloride:Urea (1:2) DES </plain></SENT>
</text></title><p><text><SENT sid="113" pm="."><plain>An equimolar ratio of the corresponding rhodanine and aldehyde was mixed together in DES. </plain></SENT>
<SENT sid="114" pm="."><plain>The mixture was heated to 90 °C and stirred until completion of the reaction (monitored by TLC). </plain></SENT>
<SENT sid="115" pm="."><plain>Upon completion, water was added to the mixture and crude product was collected by filtration. </plain></SENT>
</text></p><p><text><SENT sid="116" pm="."><plain>For investigation of DES recyclability, we performed experiments as follows: After filtration of desired product, water was evaporated under vacuum and reactants were added to DES thus obtained. </plain></SENT>
<SENT sid="117" pm="."><plain>After completion of reaction products were isolated again and the isolated yield calculated for this 2nd run. </plain></SENT>
<SENT sid="118" pm="."><plain>The same procedure was repeated for several times as stated in Table 1. </plain></SENT>
</text></p><p><text><SENT sid="119" pm="."><plain>(Z)-5-(2-methoxybenzylidene)-2-thioxothiazolidin-4-one (2a). </plain></SENT>
<SENT sid="120" pm="."><plain>Yield 47%; Rf = 0.74; Mp = 251 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 3.89 (s, 3H, OCH3), 7.07–7.10 (t, J = 7.34 Hz, 1H, arom.), 7.13–7.15 (d, J = 8.80 Hz, 1H, arom.), 7.36–7.38 (m, 1H, arom.), 7.48–7.50 (m, 1H, arom.), 7.78 (s, 1H, =CH), 13.76 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 196.01, 169.40, 158.09, 132.94, 129.61, 126.64, 125.26, 121.16, 111.92, 55.72; MS: m/z: 249.90 (M−) (251.32). </plain></SENT>
<SENT sid="121" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="122" pm="."><plain>(Z)-5-(4-(dimethylamino)benzylidene)-2-thioxothiazolidin-4-one (2b). </plain></SENT>
<SENT sid="123" pm="."><plain>Yield 78%; Rf = 0.58; Mp = 280 °C (lit. </plain></SENT>
<SENT sid="124" pm="."><plain>[35] 284–286 °C); 1H-NMR (300 MHz, ppm, DMSO-d6): 3.04 (s, 6H, 2CH3), 6.80-6.83 (d, J = 8.67 Hz, 2H, arom.), 7.40-7.43 (d, J = 9.04 Hz, 2H, arom), 7.51 (s, 1H, =CH), 13.55 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 195.49, 169.95, 152.22, 133.69, 133.35, 120.26, 117.87, 112.64, 40.00; MS: m/z: 263.10 (M−) (264.37). </plain></SENT>
<SENT sid="125" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="126" pm="."><plain>(Z)-5-(3-methoxybenzylidene)-2-thioxothiazolidin-4-one (2c). </plain></SENT>
<SENT sid="127" pm="."><plain>Yield 44%; Rf = 0.72; Mp = 246 °C (lit. </plain></SENT>
<SENT sid="128" pm="."><plain>[36] 247 °C); 1H-NMR (300 MHz, ppm, DMSO-d6): 3.81 (s, 3H, OCH3), 7.08–7.09 (dd, J = 8.07 Hz, J = 2.2 Hz, 1H, arom.), 7.15–7.16 (dd, J = 4.03 Hz, J = 1.8 Hz, 2H, arom), 7.46 (t, J = 8.07 Hz, 1H, arom.), 7.62 (s, 1H, =CH), 13.86 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 195.63, 169.31, 159.64, 134.27, 131.55, 130.53, 125.79, 122.33, 116.69, 115.55, 55.27; MS: m/z: 249.90 (M−) (251.32). </plain></SENT>
<SENT sid="129" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="130" pm="."><plain>(Z)-2-thioxo-5-(3,4,5-trimethoxybenzylidene)thiazolidin-4-one (2d). </plain></SENT>
<SENT sid="131" pm="."><plain>Yield 29%; Rf = 0.70; Mp = 190 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 3.74 (s, 3H, OCH3), 3.84 (s, 6H, 2OCH3), 6.90 (s, 2H, arom.), 7.60 (s, 1H, =CH), 13.82 (s. </plain></SENT>
<SENT sid="132" pm="."><plain>1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 195.54, 169.33, 153.22, 139.65, 131.98, 128.42, 124.31, 107.86, 60.19, 55.97; MS: m/z: 310.00 (M−) (311.38). </plain></SENT>
<SENT sid="133" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="134" pm="."><plain>(Z)-5-(3,4-dihydroxybenzylidene)-2-thioxothiazolidin-4-one (2e). </plain></SENT>
<SENT sid="135" pm="."><plain>Yield 36%; Rf = 0.42; Mp = 287–289 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 6.87 (s, 1H, arom.), 6.98–7.01 (m, 2H, arom), 7.47 (s, 1H, =CH), 9.53 (s, 1H, OH), 9.47 (s, 1H, OH), 13.67 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 196.09, 170.08, 149.67, 146.53, 133.22, 125.37, 124.83, 121.26, 117.10, 116.90; MS: m/z: 252.00 (M−) (253.30). </plain></SENT>
<SENT sid="136" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="137" pm="."><plain>(Z)-5-(4-hydroxy-3-methoxybenzylidene)-2-thioxothiazolidin-4-one (2f). </plain></SENT>
<SENT sid="138" pm="."><plain>Yield 53%; Rf = 0.67; Mp = 220 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 3.83 (s, 3H, OCH3), 6.93–6.94 (d, J = 8.1 Hz, 1H, arom.), 7.08 (m, 1H, arom.), 7.14 (s, 1H, arom.), 7.56 (s, 1H, =CH), 10.10 (s, 1H, OH), 13.66 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 195.46, 169.22, 149.95, 148.06, 132.73, 125.02, 124.33, 121.07, 116.30, 114.29, 55.59; MS: m/z: 266.00 (M−) (267.32). </plain></SENT>
<SENT sid="139" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="140" pm="."><plain>(Z)-5-(2-hydroxybenzylidene)-2-thioxothiazolidin-4-one (2g). </plain></SENT>
<SENT sid="141" pm="."><plain>Yield 32%; Rf = 0.79; Mp = 201 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 7.32–7.35 (m, 1H, arom.), 7.45–7.47 (d, J = 8.8 Hz, 2H, arom.), 7.58–7.61 (m, 1H, arom.), 7.72–7.75 (m, 1H, arom.), 8.15 (s, 1H, =CH); 13C-NMR (DMSO-d6) δ (ppm): 158.49, 151.87, 137.18, 131.58, 127.92, 124.88, 123.24, 119.18. </plain></SENT>
<SENT sid="142" pm="."><plain>116.10 MS: m/z: 236.10 (M−) (237.30). </plain></SENT>
<SENT sid="143" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="144" pm="."><plain>(Z)-5-benzylidene-2-thioxothiazolidin-4-one (2h). </plain></SENT>
<SENT sid="145" pm="."><plain>Yield 26%; Rf = 0.67; Mp = 199 °C (lit. </plain></SENT>
<SENT sid="146" pm="."><plain>202–203 °C [35,36,37,38]; 1H-NMR (300 MHz, ppm, DMSO-d6): 7.49–7.61 (m, 5H, arom.), 7.65 (s, 1H, =CH), 13.74 (s. </plain></SENT>
<SENT sid="147" pm="."><plain>1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 196.01, 170.19, 133.44, 132.06, 131.19, 130.93, 129.91; MS: m/z: 220.00 (M−) (221.30). </plain></SENT>
<SENT sid="148" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="149" pm="."><plain>(Z)-5-(pyridin-4-ylmethylene)-2-thioxothiazolidin-4-one (2i). </plain></SENT>
<SENT sid="150" pm="."><plain>Yield 30%; Rf = 0.96; Mp = 299 °C (294 °C [38]; 1H-NMR (300 MHz, ppm, DMSO-d6): 7.52–7.54 (m, 2H, pyr.), 7.58 (s, 1H, =CH), 8.72–8.74 (m, 2H, pyr.); MS: m/z: 220.90 (M−) (222.29). </plain></SENT>
<SENT sid="151" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="152" pm="."><plain>(Z)-5-(2,5-dimethoxybenzylidene)-2-thioxothiazolidin-4-one (2j). </plain></SENT>
<SENT sid="153" pm="."><plain>Yield 75%; Rf = 0.79; Mp = 240 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 3.76 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 6.87 (s, 1H, arom.), 7.08 (d, J = 1.5 Hz, 2H, arom.), 7.73 (s, 1H, =CH), 13.76 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 195.83, 169.34, 153.19, 152.55, 126.65, 125.70, 121.78, 118.50, 113.87, 113.18, 55.56; MS: m/z: 280.20 (M−) (281.35). </plain></SENT>
<SENT sid="154" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="155" pm="."><plain>(Z)-5-(4-hydroxybenzylidene)-2-thioxothiazolidin-4-one (2k). </plain></SENT>
<SENT sid="156" pm="."><plain>Yield 36%; Rf = 0.62; Mp = 285 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 6.91–6.93 (d, J = 8.8 Hz, 2H, arom.), 7.44–7.46 (d, J = 8.8 Hz, 2H, arom.), 7.55 (s, 1H, =CH), 10.4 (s, 1H, OH), 13.68 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 195.50, 169.48, 160.33, 132.28, 123.93, 120.96, 116.50, MS: m/z: 236.00 (M−) (237.30). </plain></SENT>
<SENT sid="157" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="158" pm="."><plain>(Z)-3-(4-chlorophenyl)-5-(4-hydroxy-3-methoxybenzylidene)-2-thioxothiazolidin-4-one (2l). </plain></SENT>
<SENT sid="159" pm="."><plain>Yield 72%; Rf = 0.58; Mp = 225–227 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 3.85 (s, 3H, OCH3), 6.96–6.99 (d, J = 8.1 Hz, 1H, arom.), 7.16–7.18 (d, J = 8.1 Hz, 1H, arom), 7.26 (s, 1H, arom.), 7.46–7.47 (d, J = 8.8 Hz, 2H, arom.), 7.63–7.64 (d, J = 8.1 Hz, 2H, arom.), 7.76 (s, 1H, =CH), 10.19 (s, 1H, OH); ); 13C-NMR (DMSO-d6) δ (ppm): 193.63, 166.85, 150.22, 148.13, 132.10, 130.78, 129.37, 125.12, 124.46, 118.65, 116.44, 114.65, 55.65 MS: m/z: 376.20 (M−) (377.85). </plain></SENT>
<SENT sid="160" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="161" pm="."><plain>(Z)-3-(4-chlorophenyl)-5-(4-(dimethylamino)benzylidene)-2-thioxothiazolidin-4-one (2m). </plain></SENT>
<SENT sid="162" pm="."><plain>Yield 48%; Rf = 0.77; Mp = 249–251 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 3.08 (s, 6H, 2CH3), 6.86–6.88 (m, 2H, arom.), 7.44–7.47 (m, 2H, arom.), 7.52–7.55 (m, 2H, arom), 7.62–7.65 (m, 2H, arom.), 7.73 (s, 1H, =CH); MS: m/z: 375.30 (M+) (374.90). </plain></SENT>
<SENT sid="163" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="164" pm="."><plain>(Z)-3-(4-chlorophenyl)-5-(4-hydroxybenzylidene)-2-thioxothiazolidin-4-one (2n). </plain></SENT>
<SENT sid="165" pm="."><plain>Yield 10%; Rf = 0.72; Mp = 292–294 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 6.96-6.97 (d, J = 8.8 Hz, 2H, arom.), 7.45–7.47 (m, 2H, arom), 7.55–7.56 (d, J = 8.8 Hz, 2H, arom.), 7.62–7.63 (m, 2H, arom.), 7.76 (s, 1H, =CH), 10.48 (s, 1H, OH); 13C-NMR (DMSO-d6) δ (ppm): 193.68, 166.86, 160.62, 134.16, 133.63, 133.27, 130.75, 129.25, 124.05, 118.50, 116.64; MS: m/z: 345.90 (M−) (346.85). </plain></SENT>
<SENT sid="166" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="167" pm="."><plain>(Z)-3-(4-chlorophenyl)-5-(2,5-dimethoxybenzylidene)-2-thioxothiazolidin-4-one (2o). </plain></SENT>
<SENT sid="168" pm="."><plain>Yield 32%; Rf = 0.78; Mp = 170–172 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 3.78 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.99 (s, 1H, arom.), 7.13 (d, J = 1.5 Hz, 2H, arom.), 7.43–7.46 (m, 2H, arom.), 7.60–7.63 (m, 2H, arom.), 7.90 (s, 1H, =CH); 13C-NMR (DMSO-d6) δ (ppm): 194.70, 167.18, 153.10, 134.57, 131.16, 129.85, 128.81, 122.49, 119.37, 114.95, 113.95, 56.69, 56.22; MS: m/z: 392.00 (M+) (391.89). </plain></SENT>
<SENT sid="169" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="170" pm="."><plain>(Z)-2-(5-((1,3-di-p-tolyl-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (3a). </plain></SENT>
<SENT sid="171" pm="."><plain>Yield 75%; Rf = 0.61; Mp = 240 °C (carb.); 1H-NMR (300 MHz, ppm, DMSO-d6): 2.38 (s, 3H, CH3), 2.41 (s, 3H, CH3), 4.47 (s, 2H, CH2), 7.36–7.40 (m, 4H, arom.), 7.53–7.54 (d, J = 2.3 Hz, 2H, arom.), 7.56 (s, 1H, =CH-.), 7.93–7.96 (d, J = 8.7 Hz, 2H, arom.), 8.78 (s, 1H, pyr); ); 13C-NMR (DMSO-d6) δ (ppm): 139.24, 137.59, 136.98, 130.61, 130.20, 129.17, 119.92, 119.72, 116.02, 21.1; MS: m/z: 448.20 (M−) (449.54). </plain></SENT>
<SENT sid="172" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="173" pm="."><plain>(Z)-2-(5-((3-(4-fluorophenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (3b). </plain></SENT>
<SENT sid="174" pm="."><plain>Yield 72%; Rf = 0.66; Mp = &gt;300 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 2.44 (s, 3H, CH3), 4.45 (s, 2H, CH2), 7.36–7.39 (m, 4H, arom.), 7.45 (s, 1H, =CH-), 7.69–7.71 (m, 2H, arom.), 7.93–7.96 (m, 2H, arom.), 8.78 (s, 1H, pyr); ); MS: m/z: 452.10 (M−) (453.51). </plain></SENT>
<SENT sid="175" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="176" pm="."><plain>(Z)-2-(5-((3-(4-methoxyphenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (3c). </plain></SENT>
<SENT sid="177" pm="."><plain>Yield 66%; Rf = 0.70; Mp = 250 °C (carb.); 1H-NMR (300 MHz, ppm, DMSO-d6): 2.38 (s, 3H, CH3), 3.86 (s, 3H, OCH3), 4.59 (s, 2H, CH2), 7.11–7.14 (m, 2H, arom.), 7.35–7.37 (d, J = 8.3 Hz, 2H, arom.), 7.57 (s, 1H, =CH-), 7.60-7.64 (m, 2H, arom.), 7.90–7.93 (d, J = 8.7 Hz, 2H, arom.), 8.70 (s, 1H, pyr); ); 13C-NMR (DMSO-d6) δ (ppm): 193.14, 167.13, 160.82, 137.54, 130.59, 124.39, 119.87, 114.99, 55.81, 40.19, 20.96; MS: m/z: 464.20 (M−) (465.54). </plain></SENT>
<SENT sid="178" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="179" pm="."><plain>(Z)-2-(5-((3-(4-chlorophenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (3d). </plain></SENT>
<SENT sid="180" pm="."><plain>Yield 63%; Rf = 0.84; Mp = 318 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 2.38 (s, 3H, CH3), 4.45 (s, 2H, CH2), 7.33–7.35 (m, 4H, arom.), 7.51 (s, 1H, =CH-.), 7.69–7.74 (d, J = 7.4 Hz, 2H, arom.), 7.93–7.96 (m, 2H, arom.), 8.78 (s, 1H, pyr); ); 13C-NMR (DMSO-d6) δ (ppm): 193.91, 167.51, 138.46, 131.66, 131.23, 130.31, 123.04, 120.69, 116.99, 49.65, 21.78; MS: m/z: 468.10 (M−) (469.97). </plain></SENT>
<SENT sid="181" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="182" pm="."><plain>(Z)-2-(5-((3-(4-bromophenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (3e). </plain></SENT>
<SENT sid="183" pm="."><plain>Yield 78%; Rf = 0.87; Mp = 277 °C; 1H-NMR (300 MHz, ppm, DMSO-d6): 2.39 (s, 3H, CH3), 4.41 (s, 2H, CH2), 7.35-7.37 (d, J = 8.3 Hz, 2H, arom.), 7.53 (s, 1H, =CH-), 7.61–7.64 (d, J = 8.7 Hz, 2H, arom.), 7.76–7.79 (d, J = 8.3 Hz, 2H, arom.), 7.91–7.94 (d, J = 8.7 Hz, 2H, arom.), 8.74 (s, 1H, pyr); ); 13C-NMR (DMSO-d6) δ (ppm): 193.88, 167.38, 138.62, 137.80, 133.28, 132.04, 131.22, 130.19, 123.62, 120.54, 116.84, 49.65, 21.31; MS: m/z: 514.00 (M−) (514.42). </plain></SENT>
<SENT sid="184" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p><p><text><SENT sid="185" pm="."><plain>(Z)-2-(5-((3-(4-iodophenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid (3f). </plain></SENT>
<SENT sid="186" pm="."><plain>Yield 67%; Rf = 0.89; Mp = 300 °C (carb.); 1H-NMR (300 MHz, ppm, DMSO-d6): 2.36 (s, 3H, CH3), 4.50 (s, 2H, CH2), 7.35–7.36 (d, J = 8.1 Hz, 2H, arom.), 7.44–7.46 (m, 2H, arom.), 7.51 (s, 1H, =CH−.), 7.92–7.96 (m, 4H, arom.), 8.78 (s, 1H, pyr); ); 13C-NMR (DMSO-d6) δ (ppm): 153.03, 137.73, 136.38, 130.76, 130.53, 129.86, 119.29, 115.47, 95.89, 20.33; MS: m/z: 560.10 (M−) (561.42). </plain></SENT>
<SENT sid="187" pm="."><plain>(Supplementary material 2). </plain></SENT>
</text></p></sec><sec id="sec3dot4-molecules-23-01897"><title><text><SENT sid="188" pm="."><plain>3.4. </plain></SENT>
<SENT sid="189" pm="."><plain>Antioxidant Activity </plain></SENT>
</text></title><p><text><SENT sid="190" pm="."><plain>Antioxidant activity was performed according to our previous work [39]. </plain></SENT>
<SENT sid="191" pm="."><plain>All compounds and DPPH radical were prepared in dimethyl sulfoxide (DMSO) as a solvent. </plain></SENT>
<SENT sid="192" pm="."><plain>Briefly, 750 µL of 0.2 mM solution of each compound was mixed with 750 µL of 0.2 mM DPPH radical solution, incubated for 30 minutes and absorbance of each mixture was measured at 517 nm. </plain></SENT>
<SENT sid="193" pm="."><plain>DPPH scavenging activity was calculated according to Equation (2). (2)% DPPH scavenging=Ab+As−AmAb×100, </plain></SENT>
</text></p><p><text><SENT sid="194" pm="."><plain>Ab—absorbance of 0.1 mM DMSO solution of DPPH radical at 517 nm. </plain></SENT>
</text></p><p><text><SENT sid="195" pm="."><plain>As—absorbance of 0.1 mM DMSO solution of test compound at 517 nm. </plain></SENT>
</text></p><p><text><SENT sid="196" pm="."><plain>Am—absorbance of DMSO mixture of test compound and DPPH radical at 517 nm. </plain></SENT>
</text></p></sec><sec id="sec3dot5-molecules-23-01897"><title><text><SENT sid="197" pm="."><plain>3.5. </plain></SENT>
<SENT sid="198" pm="."><plain>QSAR Method </plain></SENT>
</text></title><sec id="sec3dot5dot1-molecules-23-01897"><title><text><SENT sid="199" pm="."><plain>3.5.1. </plain></SENT>
<SENT sid="200" pm="."><plain>Data Set </plain></SENT>
</text></title><p><text><SENT sid="201" pm="."><plain>The dataset used for building QSAR models consists of 21 molecules whose antioxidant activities were measured and described in the present study. </plain></SENT>
<SENT sid="202" pm="."><plain>Antioxidant activity, expressed as % DPPH, were converted in the form of the negative logarithm of % DPPH/100 (pDPPH) and presented in Table 2. </plain></SENT>
</text></p></sec><sec id="sec3dot5dot2-molecules-23-01897"><title><text><SENT sid="203" pm="."><plain>3.5.2. </plain></SENT>
<SENT sid="204" pm="."><plain>Descriptor Calculation </plain></SENT>
</text></title><p><text><SENT sid="205" pm="."><plain>The 3D structures of 21 molecules were optimized applying the Avogadro 1.2.0. </plain></SENT>
<SENT sid="206" pm="."><plain>(University of Pittsburgh, Pittsburgh, PA, USA) using the molecular mechanics force field (MM+) [40]. </plain></SENT>
<SENT sid="207" pm="."><plain>Subsequently, all structures were submitted to geometry optimization using the semiempirical AM1 method [39]. </plain></SENT>
<SENT sid="208" pm="."><plain>Two sets of descriptors were generated using Parameter Client (Virtual Computational Chemistry Laboratory, an electronic remote version of the Dragon program [41] and by ADMEWORKS ModelBuilder [42]. </plain></SENT>
<SENT sid="209" pm="."><plain>In order to reduce the huge number of calculated descriptors, firstly, zero value descriptors were excluded from the initial pool. </plain></SENT>
<SENT sid="210" pm="."><plain>Further exclusion was performed using QSARINS-Chem 2.2.1 (University of Insubria, Varese, Italy) [43]: Constant and semi-constant descriptors, i.e., those having chemical compounds with a constant value for more than 80%, and descriptors that are too inter-correlated (&gt;85%) were rejected. </plain></SENT>
</text></p></sec><sec id="sec3dot5dot3-molecules-23-01897"><title><text><SENT sid="211" pm="."><plain>3.5.3. </plain></SENT>
<SENT sid="212" pm="."><plain>Regression Analysis and Validation of Models </plain></SENT>
</text></title><p><text><SENT sid="213" pm="."><plain>The best QSAR model was obtained by using a Genetic Algorithm (GA) using QSARINS. </plain></SENT>
<SENT sid="214" pm="."><plain>The number of descriptors (I) in the multiple regression equation was limited on two. </plain></SENT>
<SENT sid="215" pm="."><plain>The models have been assessed by: Fitting criteria; internal cross-validation using leave-one out (LOO) method. </plain></SENT>
<SENT sid="216" pm="."><plain>Robustness of QSAR models was tested by Y-randomization test. </plain></SENT>
<SENT sid="217" pm="."><plain>Considering a limited number of compounds, external validation was not possible. </plain></SENT>
<SENT sid="218" pm="."><plain>Fitting criteria included: The coefficient of determination (R2), adjusted R2 (R2adj), cross-validate R2 using leave-one-out method (Q2loo), global correlation among descriptors (Kxx), difference between global correlation between molecular descriptors and y the response variable, and global correlation among descriptors (ΔK), standard deviation of regression (s), and Fisher ratio (F). </plain></SENT>
<SENT sid="219" pm="."><plain>Internal validations also included the following parameters: Root-mean-square error of the training set (RMSEtr); root-mean-square error of the training set determined through cross validated LOO method (RMSEcv), concordance correlation coefficient of the training set (CCCtr), test set using LOO cross validation (CCCcv), mean absolute error of the training set (MAEtr), mean absolute error of the internal validation set (MAEcv), predictive residual sum of squares determined through cross-validated LOO method (PRESScv) in the training set. </plain></SENT>
</text></p><p><text><SENT sid="220" pm="."><plain>Investigation of the applicability domain of a prediction model was performed by leverage plot (plotting residuals vs. leverage of training compounds). </plain></SENT>
<SENT sid="221" pm="."><plain>The warning leverage h* is defined as 3p′/n, where n is the number of training compounds and p′ is the number of model adjustable parameters [44]. </plain></SENT>
</text></p><p><text><SENT sid="222" pm="."><plain>Investigation of the applicability domain of obtained model was performed by leverage plot (Williams plots) using QSARINS. </plain></SENT>
<SENT sid="223" pm="."><plain>External validation of model was left out due to a relatively small number of compounds. </plain></SENT>
<SENT sid="224" pm="."><plain>Robustness of QSAR model was tested by Y-randomization test. </plain></SENT>
</text></p></sec></sec><sec id="sec3dot6-molecules-23-01897"><title><text><SENT sid="225" pm="."><plain>3.6. </plain></SENT>
<SENT sid="226" pm="."><plain>Molecular Docking </plain></SENT>
</text></title><p><text><SENT sid="227" pm="."><plain>The molecular docking of the most active compound 2e was performed with iGEMDOCK (BioXGEM, Taiwan). </plain></SENT>
<SENT sid="228" pm="."><plain>Crystal coordinates of the haematopoietic cell tyrosine kinase (PDB ID: 2HCK) in the complex with quercetin was downloaded from Protein Dana Bank (https://www.rcsb.org/structure/2HCK). </plain></SENT>
<SENT sid="229" pm="."><plain>In the first step, structure of 2HCK was prepared, including the removal of water molecules and optimized protein structure using PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC, New York, NY, USA). </plain></SENT>
<SENT sid="230" pm="."><plain>Binding site of protein was defined according the bounded ligand. </plain></SENT>
<SENT sid="231" pm="."><plain>After preparing the protein target and optimized structure of the compound 2e as a ligand, genetic parameters were set (population size 200; generations: 70; number of solution or poses: 2). </plain></SENT>
<SENT sid="232" pm="."><plain>The compound was docked into the binding site and protein-compound interaction profiles of electrostatic (Elec), hydrogen-bonding (Hbond), and van der Waals (vdW) interactions were generated. </plain></SENT>
<SENT sid="233" pm="."><plain>Energy-based scoring function or total energy (E) is: E = vdW + Hbond + Elec [45]. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="CONCL"><sec id="sec4-molecules-23-01897"><title><text><SENT sid="234" pm="."><plain>4. </plain></SENT>
<SENT sid="235" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="236" pm="."><plain>A series of rhodanine derivatives were synthesized in the Knoevenagel condensation of rhodanine and different aldehydes in deep eutectic solvent. </plain></SENT>
<SENT sid="237" pm="."><plain>Among all the synthesized compounds, benzylidene derivative of 5-aryldenerhodanines with in 3,4-hydroxyl moiety on phenyl ring exhibited the best DPPH radical scavenging activity. </plain></SENT>
<SENT sid="238" pm="."><plain>QSAR analysis revealed the importance of the following characteristics for antioxidant activity: Sphericity of molecule, ratio of symmetric atoms enhanced atomic mass along the principle axes regards to total number of atoms in molecule, and 3D distribution of the atoms higher electronegativity (O, N, and S) in molecules. </plain></SENT>
<SENT sid="239" pm="."><plain>Presences of hydroxyl groups and atoms of higher electronegativity are important for formation of interaction with tyrosine kinase. </plain></SENT>
<SENT sid="240" pm="."><plain>Molecular docking study confirmed that the most active compound binds to the tyrosine kinase Hck, at the same binding site as quercetin, mostly throughout the hydrogen bonds. </plain></SENT>
</text></p></sec></SecTag></body><back><fn-group><fn><p><text><SENT sid="241" pm="."><plain>Sample Availability: Samples of all compounds are available from the authors. </plain></SENT>
</text></p></fn></fn-group><SecTag type="APPENDIX"><app-group><app id="app1-molecules-23-01897"><title>Supplementary Materials</title><p>Supplementary materials are available on line.</p><supplementary-material content-type="local-data" id="molecules-23-01897-s001"><media xlink:href="molecules-23-01897-s001.zip"><caption><p><text><SENT sid="242" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></app></app-group></SecTag><notes><title>Author Contributions</title><p>Conceptualization, M.M. and J.B.; Methodology, H.B., M.K. (Mario Komar), V.P.; Software, V.R. and M.K. (Maja Karnaš); Validation, M.M., J.B. and V.R.; Formal Analysis, V.R.; Investigation, M.M., H.B., V.P., M.K. (Mario Komar); Resources, M.M.; Data Curation, M.M., V.R., J.B.; Writing—Original Draft Preparation, M.M., V.R.; Writing—Review &amp; Editing, M.M., V.R.; Visualization, M.M.; Supervision, M.M.; Project Administration, M.M.; Funding Acquisition, M.M.</p></notes><notes><title>Funding</title><p>This work has been supported in part by Croatian Science Foundation under the project “Green Technologies in Synthesis of Heterocyclic Compounds” (UIP-2017-05-6593).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><SecTag type="REF"><ref-list><title>References</title><ref id="B1-molecules-23-01897"><text><SENT sid="243" pm="."><plain>1.AziziN.DezfooliS.KhajehM.HashemiM.M.Efficient deep eutectic solvents catalyzed synthesis of pyran and benzopyran derivativesJ. </plain></SENT>
<SENT sid="244" pm="."><plain>Mol. </plain></SENT>
<SENT sid="245" pm="."><plain>Liq.2013186768010.1016/j.molliq.2013.05.011 </plain></SENT>
</text></ref><ref id="B2-molecules-23-01897"><text><SENT sid="246" pm="."><plain>2.DaiY.van SpronsenJ.WitkampG.-J.VerpoorteR.ChoiY.H.Natural deep eutectic solvents as new potential media for green technologyAnal. </plain></SENT>
<SENT sid="247" pm="."><plain>Chim. </plain></SENT>
<SENT sid="248" pm="."><plain>Acta2013766616810.1016/j.aca.2012.12.019<?supplied-pmid 23427801?>23427801 </plain></SENT>
</text></ref><ref id="B3-molecules-23-01897"><text><SENT sid="249" pm="."><plain>3.GarcíaA.Rodríguez-JuanE.Rodríguez-GutiérrezG.RiosJ.J.Fernández-BolañosJ.Extraction of phenolic compounds from virgin olive oil by deep eutectic solvents (DESs)Food Chem.201619755456110.1016/j.foodchem.2015.10.131<?supplied-pmid 26616988?>26616988 </plain></SENT>
</text></ref><ref id="B4-molecules-23-01897"><text><SENT sid="250" pm="."><plain>4.HarishkumarH.N.MahadevanK.M.KumarC.K.SatyanarayanN.D.A facile, choline chloride/urea catalyzed solid phase synthesis of coumarins via Knoevenagel condensationOrg. </plain></SENT>
<SENT sid="251" pm="."><plain>Commun.2011426 </plain></SENT>
</text></ref><ref id="B5-molecules-23-01897"><text><SENT sid="252" pm="."><plain>5.KhandelwalS.TailorY.K.KumarM.Deep eutectic solvents (DESs) as eco-friendly and sustainable solvent/catalyst systems in organic transformationsJ. </plain></SENT>
<SENT sid="253" pm="."><plain>Mol. </plain></SENT>
<SENT sid="254" pm="."><plain>Liq.201621534538610.1016/j.molliq.2015.12.015 </plain></SENT>
</text></ref><ref id="B6-molecules-23-01897"><text><SENT sid="255" pm="."><plain>6.LoboH.R.SinghB.S.ShankarlingG.S.Bio-compatible eutectic mixture for multi-component synthesis: A valuable acidic catalyst for synthesis of novel 2,3-dihydroquinazolin-4(1H)-one derivativesCatal. </plain></SENT>
<SENT sid="256" pm="."><plain>Commun.20122717918310.1016/j.catcom.2012.07.020 </plain></SENT>
</text></ref><ref id="B7-molecules-23-01897"><text><SENT sid="257" pm="."><plain>7.MoreP.A.GadiloharB.L.ShankarlingG.S.In Situ Generated Cetyltrimethylammonium Bisulphate in Choline Chloride—Urea Deep Eutectic Solvent: A Novel Catalytic System for One Pot Synthesis of 1,3,4-OxadiazoleCatal. </plain></SENT>
<SENT sid="258" pm="."><plain>Lett.201481393139810.1007/s10562-014-1288-3 </plain></SENT>
</text></ref><ref id="B8-molecules-23-01897"><text><SENT sid="259" pm="."><plain>8.PednekarS.BhaleraoR.GhadgeN.One-pot multi-component synthesis of 1,4-dihydropyridine derivatives in biocompatible deep eutectic solventsJ. </plain></SENT>
<SENT sid="260" pm="."><plain>Chem. </plain></SENT>
<SENT sid="261" pm="."><plain>Sci.201312561562110.1007/s12039-013-0399-5 </plain></SENT>
</text></ref><ref id="B9-molecules-23-01897"><text><SENT sid="262" pm="."><plain>9.RajawatA.KhandelwalS.KumarM.Deep eutectic solvent promoted efficient and environmentally benign four-component domino protocol for synthesis of spirooxindolesRSC Adv.201445105511210.1039/c3ra44600j </plain></SENT>
</text></ref><ref id="B10-molecules-23-01897"><text><SENT sid="263" pm="."><plain>10.ZhuA.JiangT.HanB.ZhangJ.XieY.MaX.Supported choline chloride/urea as a heterogeneous catalyst for chemical fixation of carbon dioxide to cyclic carbonatesGreen Chem.2007916917210.1039/B612164K </plain></SENT>
</text></ref><ref id="B11-molecules-23-01897"><text><SENT sid="264" pm="."><plain>11.De SantiV.CardelliniF.BrinchiL.GermaniR.Novel Brønsted acidic deep eutectic solvent as reaction media for esterification of carboxylic acid with alcoholsTetrahedron Lett.2012535151515510.1016/j.tetlet.2012.07.063 </plain></SENT>
</text></ref><ref id="B12-molecules-23-01897"><text><SENT sid="265" pm="."><plain>12.MartínezR.BerbegalL.GuillenaG.RamónD.J.Bio-renewable enantioselective aldol reaction in natural deep eutectic solventsGreen Chem.2016181724173010.1039/C5GC02526E </plain></SENT>
</text></ref><ref id="B13-molecules-23-01897"><text><SENT sid="266" pm="."><plain>13.PhadtareS.B.ShankarlingG.S.Halogenation reactions in biodegradable solvent: Efficient bromination of substituted 1-aminoanthra-9,10-quinone in deep eutectic solvent (choline chloride: Urea)Green Chem.20101245846210.1039/b923589b </plain></SENT>
</text></ref><ref id="B14-molecules-23-01897"><text><SENT sid="267" pm="."><plain>14.AmićA.MolnarM.An Improved and Efficient N-acetylation of Amines Using Choline Chloride Based Deep Eutectic SolventsOrg. </plain></SENT>
<SENT sid="268" pm="."><plain>Prep. </plain></SENT>
<SENT sid="269" pm="."><plain>Proced. </plain></SENT>
<SENT sid="270" pm="."><plain>Int.20174924925710.1080/00304948.2017.1320914 </plain></SENT>
</text></ref><ref id="B15-molecules-23-01897"><text><SENT sid="271" pm="."><plain>15.MolnarM.KlenkarJ.TarnaiT.Eco-friendly rapid synthesis of 3-substituted-2-thioxo-2,3-dihydroquinazolin-4(1H)-ones in choline chloride based deep eutectic solventSynth. </plain></SENT>
<SENT sid="272" pm="."><plain>Commun.2017471040104510.1080/00397911.2017.1291815 </plain></SENT>
</text></ref><ref id="B16-molecules-23-01897"><text><SENT sid="273" pm="."><plain>16.MolnarM.KomarM.BrahmbhattH.BabićJ.JokićS.RastijaV.Deep Eutectic Solvents as Convenient Media for Synthesis of Novel Coumarinyl Schiff Bases and Their QSAR StudiesMolecules201722148210.3390/molecules22091482<?supplied-pmid 28872604?>28872604 </plain></SENT>
</text></ref><ref id="B17-molecules-23-01897"><text><SENT sid="274" pm="."><plain>17.KeshavarzipourF.TavakolH.The synthesis of coumarin derivatives using choline chloride/zinc chloride as a deep eutectic solventJ. </plain></SENT>
<SENT sid="275" pm="."><plain>Iran. </plain></SENT>
<SENT sid="276" pm="."><plain>Chem. </plain></SENT>
<SENT sid="277" pm="."><plain>Soc.20161314915310.1007/s13738-015-0722-9 </plain></SENT>
</text></ref><ref id="B18-molecules-23-01897"><text><SENT sid="278" pm="."><plain>18.YarovenkoV.N.NikitinaA.S.ZavarzinI.V.KrayushkinM.M.KovalenkoL.V.Synthesis of 2-thioxo-1,3-thiazolidin-4-one derivativesRuss. </plain></SENT>
<SENT sid="279" pm="."><plain>Chem. </plain></SENT>
<SENT sid="280" pm="."><plain>Bull.2007561624163010.1007/s11172-007-0254-2 </plain></SENT>
</text></ref><ref id="B19-molecules-23-01897"><text><SENT sid="281" pm="."><plain>19.RadiM.BottaL.CasaluceG.BernardiniM.BottaM.Practical one-pot two-step protocol for the microwave-assisted synthesis of highly functionalized rhodanine derivativesJ. </plain></SENT>
<SENT sid="282" pm="."><plain>Comb. </plain></SENT>
<SENT sid="283" pm="."><plain>Chem.20101220020510.1021/cc9001789<?supplied-pmid 20028090?>20028090 </plain></SENT>
</text></ref><ref id="B20-molecules-23-01897"><text><SENT sid="284" pm="."><plain>20.NitscheC.KleinC.D.Aqueous microwave-assisted one-pot synthesis of N-substituted rhodaninesTetrahedron Lett.2012535197520110.1016/j.tetlet.2012.07.002 </plain></SENT>
</text></ref><ref id="B21-molecules-23-01897"><text><SENT sid="285" pm="."><plain>21.AziziN.HasaniM.KhajehM.EdrisiM.A straightforward and sustainable one-pot, four-component synthesis of rhodanine derivativesTetrahedron Lett.2015561189119210.1016/j.tetlet.2015.01.102 </plain></SENT>
</text></ref><ref id="B22-molecules-23-01897"><text><SENT sid="286" pm="."><plain>22.SandhuJ.S.Ultrasound-assisted synthesis of 2,4-thiazolidinedione and rhodanine derivatives catalyzed by task-specific ionic liquid: [TMG][Lac]Org. </plain></SENT>
<SENT sid="287" pm="."><plain>Med. </plain></SENT>
<SENT sid="288" pm="."><plain>Chem. </plain></SENT>
<SENT sid="289" pm="."><plain>Lett.20133210.1186/2191-2858-3-223458122 </plain></SENT>
</text></ref><ref id="B23-molecules-23-01897"><text><SENT sid="290" pm="."><plain>23.ZervosenA.LuW.-P.ChenZ.WhiteR.E.DemuthT.P.FrèreJ.-M.Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-onesAntimicrob. </plain></SENT>
<SENT sid="291" pm="."><plain>Agents Chemother.20044896196910.1128/AAC.48.3.961-969.2004<?supplied-pmid 14982790?>14982790 </plain></SENT>
</text></ref><ref id="B24-molecules-23-01897"><text><SENT sid="292" pm="."><plain>24.DayamR.SanchezT.ClementO.ShoemakerR.SeiS.NeamatiN.β-Diketo Acid Pharmacophore Hypothesis. </plain></SENT>
<SENT sid="293" pm="."><plain>1. </plain></SENT>
<SENT sid="294" pm="."><plain>Discovery of a Novel Class of HIV-1 Integrase InhibitorsJ. </plain></SENT>
<SENT sid="295" pm="."><plain>Med. </plain></SENT>
<SENT sid="296" pm="."><plain>Chem.20054811112010.1021/jm0496077<?supplied-pmid 15634005?>15634005 </plain></SENT>
</text></ref><ref id="B25-molecules-23-01897"><text><SENT sid="297" pm="."><plain>25.TakasuK.PudhomK.KaiserM.BrunR.IharaM.Synthesis and Antimalarial Efficacy of Aza-Fused Rhodacyanines in vitro and in the P. berghei Mouse ModelJ. </plain></SENT>
<SENT sid="298" pm="."><plain>Med. </plain></SENT>
<SENT sid="299" pm="."><plain>Chem.2006494795479810.1021/jm0606241<?supplied-pmid 16854088?>16854088 </plain></SENT>
</text></ref><ref id="B26-molecules-23-01897"><text><SENT sid="300" pm="."><plain>26.SortinoM.DelgadoP.JuárezS.QuirogaJ.AboníaR.InsuastyB.NoguerasM.RoderoL.GaribottoF.M.EnrizR.D.Synthesis and antifungal activity of (Z)-5-arylidenerhodaninesBioorg. </plain></SENT>
<SENT sid="301" pm="."><plain>Med. </plain></SENT>
<SENT sid="302" pm="."><plain>Chem.20071548449410.1016/j.bmc.2006.09.038<?supplied-pmid 17049255?>17049255 </plain></SENT>
</text></ref><ref id="B27-molecules-23-01897"><text><SENT sid="303" pm="."><plain>27.ChenH.FanY.-H.NatarajanA.GuoY.IyasereJ.HarbinskiF.LuusL.ChristW.AktasH.HalperinJ.A.Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiationBioorg. </plain></SENT>
<SENT sid="304" pm="."><plain>Med. </plain></SENT>
<SENT sid="305" pm="."><plain>Chem. </plain></SENT>
<SENT sid="306" pm="."><plain>Lett.2004145401540510.1016/j.bmcl.2004.08.017<?supplied-pmid 15454234?>15454234 </plain></SENT>
</text></ref><ref id="B28-molecules-23-01897"><text><SENT sid="307" pm="."><plain>28.LiJ.PangQ.Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemiaAntioxid. </plain></SENT>
<SENT sid="308" pm="."><plain>Redox Signal.2014202290230110.1089/ars.2013.5715<?supplied-pmid 24206276?>24206276 </plain></SENT>
</text></ref><ref id="B29-molecules-23-01897"><text><SENT sid="309" pm="."><plain>29.MasandV.H.MahajanD.T.NazeruddinG.M.HaddaT.B.RastijaV.AlfeefyA.M.Effect of information leakage and method of splitting (rational and random) on external predictive ability and behavior of different statistical parameters of QSAR modelMed. </plain></SENT>
<SENT sid="310" pm="."><plain>Chem. </plain></SENT>
<SENT sid="311" pm="."><plain>Res.2015241241126410.1007/s00044-014-1193-8 </plain></SENT>
</text></ref><ref id="B30-molecules-23-01897"><text><SENT sid="312" pm="."><plain>30.TodeschiniR.ConsonniV.Handbook of Molecular DescriptorsJohn Wiley &amp; SonsHoboken, NJ, USA2008978-3-527-61311-3 </plain></SENT>
</text></ref><ref id="B31-molecules-23-01897"><text><SENT sid="313" pm="."><plain>31.DevinyakO.HavrylyukD.LesykR.3D-MoRSE descriptors explainedJ. </plain></SENT>
<SENT sid="314" pm="."><plain>Mol. </plain></SENT>
<SENT sid="315" pm="."><plain>Graph. </plain></SENT>
<SENT sid="316" pm="."><plain>Model.20145419420310.1016/j.jmgm.2014.10.006<?supplied-pmid 25459771?>25459771 </plain></SENT>
</text></ref><ref id="B32-molecules-23-01897"><text><SENT sid="317" pm="."><plain>32.TodeschiniR.GramaticaP.3D-modelling and Prediction by WHIM Descriptors. </plain></SENT>
<SENT sid="318" pm="."><plain>Part 6. </plain></SENT>
<SENT sid="319" pm="."><plain>Application of WHIM Descriptors in QSAR StudiesQuant. </plain></SENT>
<SENT sid="320" pm="."><plain>Struct.-Act. </plain></SENT>
<SENT sid="321" pm="."><plain>Relatsh.19971612012510.1002/qsar.19970160204 </plain></SENT>
</text></ref><ref id="B33-molecules-23-01897"><text><SENT sid="322" pm="."><plain>33.SicheriF.MoarefiI.KuriyanJ.Crystal structure of the Src family tyrosine kinase HckNature199738560260910.1038/385602a0<?supplied-pmid 9024658?>9024658 </plain></SENT>
</text></ref><ref id="B34-molecules-23-01897"><text><SENT sid="323" pm="."><plain>34.PohA.R.O’DonoghueR.J.J.ErnstM.Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cellsOncotarget20156157521577110.18632/oncotarget.4199<?supplied-pmid 26087188?>26087188 </plain></SENT>
</text></ref><ref id="B35-molecules-23-01897"><text><SENT sid="324" pm="."><plain>35.SubhedarD.D.ShaikhM.H.NawaleL.YewareA.SarkarD.ShingateB.B.[Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activityRes. </plain></SENT>
<SENT sid="325" pm="."><plain>Chem. </plain></SENT>
<SENT sid="326" pm="."><plain>Intermed.2016426607662610.1007/s11164-016-2484-0 </plain></SENT>
</text></ref><ref id="B36-molecules-23-01897"><text><SENT sid="327" pm="."><plain>36.SwathiT.SrinivasM.Green condensation reaction of aromatic aldehydes with rhodanine catalyzed by alum under microwave irradiationDer Pharma Chem.20155100104 </plain></SENT>
</text></ref><ref id="B37-molecules-23-01897"><text><SENT sid="328" pm="."><plain>37.BhattiR.S.SinghM.SandhuJ.S.Microwave Enhanced Synthesis OF 5-Arylidene Rhodanine under solvent free conditions using bismuth trichloride as a promoterRasayan J. Chem.20085738742 </plain></SENT>
</text></ref><ref id="B38-molecules-23-01897"><text><SENT sid="330" pm="."><plain>38.KumarD.NarwalS.SandhuJ.S.Catalyst-free synthesis of highly biologically active 5-arylidene rhodanine and 2,4-thiazolidinedione derivatives using aldonitrones in polyethylene glycolInt. </plain></SENT>
<SENT sid="331" pm="."><plain>J. </plain></SENT>
<SENT sid="332" pm="."><plain>Med. </plain></SENT>
<SENT sid="333" pm="."><plain>Chem.2013201327353410.1155/2013/273534<?supplied-pmid 25374689?>25374689 </plain></SENT>
</text></ref><ref id="B39-molecules-23-01897"><text><SENT sid="334" pm="."><plain>39.ŠarkanjB.MolnarM.ČačićM.GilleL.4-Methyl-7-hydroxycoumarin antifungal and antioxidant activity enhancement by substitution with thiosemicarbazide and thiazolidinone moietiesFood Chem.201313948849510.1016/j.foodchem.2013.01.027<?supplied-pmid 23561135?>23561135 </plain></SENT>
</text></ref><ref id="B40-molecules-23-01897"><text><SENT sid="335" pm="."><plain>40.HocquetA.LanggårdM.An Evaluation of the MM+ Force FieldJ. </plain></SENT>
<SENT sid="336" pm="."><plain>Mol. </plain></SENT>
<SENT sid="337" pm="."><plain>Med.199849411210.1007/s008940050128 </plain></SENT>
</text></ref><ref id="B41-molecules-23-01897"><text><SENT sid="338" pm="."><plain>41.TetkoI.V.GasteigerJ.TodeschiniR.MauriA.LivingstoneD.ErtlP.PalyulinV.A.RadchenkoE.V.ZefirovN.S.MakarenkoA.S.Virtual computational chemistry laboratory—Design and descriptionJ. </plain></SENT>
<SENT sid="339" pm="."><plain>Comput. </plain></SENT>
<SENT sid="340" pm="."><plain>Aided Mol. </plain></SENT>
<SENT sid="341" pm="."><plain>Des.20051945346310.1007/s10822-005-8694-y<?supplied-pmid 16231203?>16231203 </plain></SENT>
</text></ref><ref id="B42-molecules-23-01897"><text><SENT sid="342" pm="."><plain>42.ADMEWORKS: Fujitsu Kyushu SystemsAvailable online: <ext-link ext-link-type="uri" xlink:href="http://www.fujitsu.com/jp/group/kyushu/en/solutions/industry/lifescience/admeworks/">http://www.fujitsu.com/jp/group/kyushu/en/solutions/industry/lifescience/admeworks/</ext-link>(accessed on 15 May 2018) </plain></SENT>
</text></ref><ref id="B43-molecules-23-01897"><text><SENT sid="343" pm="."><plain>43.GramaticaP.ChiricoN.PapaE.CassaniS.KovarichS.QSARINS: A new software for the development, analysis, and validation of QSAR MLR modelsJ. </plain></SENT>
<SENT sid="344" pm="."><plain>Comput. </plain></SENT>
<SENT sid="345" pm="."><plain>Chem.2013342121213210.1002/jcc.23361 </plain></SENT>
</text></ref><ref id="B44-molecules-23-01897"><text><SENT sid="346" pm="."><plain>44.Wiley Online LibraryPrinciples of QSAR models validation: Internal and external-GramaticaQSAR &amp; Combinatorial Science2007Available online: <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/abs/10.1002/qsar.200610151">https://onlinelibrary.wiley.com/doi/abs/10.1002/qsar.200610151</ext-link>(accessed on 15 May 2018) </plain></SENT>
</text></ref><ref id="B45-molecules-23-01897"><text><SENT sid="347" pm="."><plain>45.HsuK.-C.ChenY.-F.LinS.-R.YangJ.-M.iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysisBMC Bioinform.201112Suppl. </plain></SENT>
<SENT sid="348" pm="."><plain>S1S3310.1186/1471-2105-12-S1-S33<?supplied-pmid 21342564?>21342564 </plain></SENT>
</text></ref></ref-list></SecTag><sec sec-type="display-objects"><title>Figures, Scheme and Tables</title><SecTag type="FIG"><fig id="molecules-23-01897-sch001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-01897-sch001_Scheme 1</object-id><label>Scheme 1</label><caption><p><text><SENT sid="349" pm="."><plain>Synthesis of rhodanine derivatives via Knoevenagel condensation (R: 2a: 2-OCH3; 2b: 4-N(CH3)2; 2c: 3-OCH3; 2d: 3,4,5-(OCH3)3; 2e: 3,4-(OH)2; 2f: 3-OCH3, 4-OH; 2g: 2-OH; 2h: H; 2i: 4-pyridyl; 2j: 2,5-(OCH3)2; 2k: 4-OH; 2l: 3-OCH3, 4-OH; 2m: 4-N(CH3)2; 2n: 4-OH; 2o: 2,5-(OCH3)2; 3a: R1 = CH2COOH, R2 = CH3, R3 = CH3; 3b: R1 = CH2COOH, R2 = F, R3 = CH3; 3c: R1 = CH2COOH, R2 = OCH3, R3 = CH3; 3d: R1 = CH2COOH, R2 = Cl, R3 = CH3; 3e: R1 = CH2COOH, R2 = Br, R3 = CH3; 3f: R1 = CH2COOH, R2 = I, R3 = CH3). </plain></SENT>
</text></p></caption><graphic xlink:href="molecules-23-01897-sch001"/></fig></SecTag><SecTag type="FIG"><fig id="molecules-23-01897-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="350" pm="."><plain>Williams plot of the applicability domain of the quantitative structure-activity relationship (QSAR) model for antioxidant activity calculated by model (1). </plain></SENT>
</text></p></caption><graphic xlink:href="molecules-23-01897-g001"/></fig></SecTag><SecTag type="FIG"><fig id="molecules-23-01897-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p><text><SENT sid="351" pm="."><plain>Observed versus predicted log DPPH for the 21 derivatives of rhodanine calculated by model (1). </plain></SENT>
</text></p></caption><graphic xlink:href="molecules-23-01897-g002"/></fig></SecTag><SecTag type="FIG"><fig id="molecules-23-01897-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p><text><SENT sid="352" pm="."><plain>Interactions of the most active compound 2e with the nearby amino acid group of the tyrosine kinase Hck. </plain></SENT>
<SENT sid="353" pm="."><plain>The following rows show the interactions between the active compounds and the interacting residue groups. </plain></SENT>
<SENT sid="354" pm="."><plain>H and V indicate the interaction types (H bond and van der Waals interactions, respectively); M and S indicate the main chain and the side chain of the interacting residue, respectively. </plain></SENT>
<SENT sid="355" pm="."><plain>The hydrogen-bondings are coloured in green and van der Waals (white) if the energy ≤−2.5. </plain></SENT>
<SENT sid="356" pm="."><plain>Docking pose of ligand is pink, where yellow denotes sulphur atoms and blue nitrogen atom. </plain></SENT>
</text></p></caption><graphic xlink:href="molecules-23-01897-g003"/></fig></SecTag><SecTag type="FIG"><fig id="molecules-23-01897-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p><text><SENT sid="357" pm="."><plain>Surface representation of: (a) The entire tyrosine kinase hematopoietic cell kinase (Hck); and (b) a segment of tyrosine kinase Hck active site with docked compound 2e. </plain></SENT>
</text></p></caption><graphic xlink:href="molecules-23-01897-g004"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="molecules-23-01897-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-01897-t001_Table 1</object-id><label>Table 1</label><caption><p><text><SENT sid="358" pm="."><plain>Influence of DES recycle on the yield of the final product. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>Solvent </plain></SENT>
</text></th><th align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>Yield (%) </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>choline chloride:urea </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>78 </plain></SENT>
</text></td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>1st recycle </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>78 </plain></SENT>
</text></td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>2nd recycle </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>74 </plain></SENT>
</text></td></tr><tr><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>3rd recycle </plain></SENT>
</text></td><td align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>76 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="molecules-23-01897-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-01897-t002_Table 2</object-id><label>Table 2</label><caption><p><text><SENT sid="369" pm="."><plain>Structure and the observed antioxidant activity of rhodanine derivatives expressed as % 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) scavenging and negative value of % DPPH/100 (pDPPH). </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="15" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="370" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="371" pm="."><plain>Cmp. </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="372" pm="."><plain>R1 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="373" pm="."><plain>%DPPH </plain></SENT>
</text></td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="374" pm="."><plain>pDPPH </plain></SENT>
</text></td></tr><tr><td colspan="3" align="center" valign="middle" rowspan="1"><text><SENT sid="375" pm="."><plain>1 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" rowspan="1"><text><SENT sid="376" pm="."><plain>H </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" rowspan="1"><text><SENT sid="377" pm="."><plain>3.6 </plain></SENT>
</text></td><td colspan="3" align="center" valign="middle" rowspan="1"><text><SENT sid="378" pm="."><plain>1.444 </plain></SENT>
</text></td></tr><tr><td colspan="3" align="center" valign="middle" rowspan="1"><text><SENT sid="379" pm="."><plain>2 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" rowspan="1"><text><SENT sid="380" pm="."><plain>p-Cl-phenyl </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" rowspan="1"><text><SENT sid="381" pm="."><plain>94.4 </plain></SENT>
</text></td><td colspan="3" align="center" valign="middle" rowspan="1"><text><SENT sid="382" pm="."><plain>0.025 </plain></SENT>
</text></td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="383" pm="."><plain>3 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="384" pm="."><plain>CH2COOH </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="385" pm="."><plain>23.9 </plain></SENT>
</text></td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="386" pm="."><plain>0.622 </plain></SENT>
</text></td></tr><tr><td colspan="15" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="387" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>Cmp. </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>Ar </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="390" pm="."><plain>R1 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>% DPPH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="392" pm="."><plain>pDPPH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="393" pm="."><plain>Cmp. </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="394" pm="."><plain>Ar </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="395" pm="."><plain>R1 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>% DPPH </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>pDPPH </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>2a </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>2-OCH3-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="400" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>9.2 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="402" pm="."><plain>1.036 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="403" pm="."><plain>2i </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="404" pm="."><plain>4-pyridyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="405" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>21.5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>0.668 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>2b </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>4-N(CH3)2-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="410" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>1.1 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="412" pm="."><plain>1.959 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="413" pm="."><plain>2j </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="414" pm="."><plain>2,5-(OCH3)2-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="415" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>13.9 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>0.857 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>2c </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>3-OCH3-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="420" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>15.7 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="422" pm="."><plain>0.804 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="423" pm="."><plain>2k </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="424" pm="."><plain>4-OH-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="425" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>5.8 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>1.237 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>2d </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>3,4,5-(OCH3)3-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="430" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>10.1 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="432" pm="."><plain>0.996 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="433" pm="."><plain>2l </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="434" pm="."><plain>3-OH-4-OCH3-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="435" pm="."><plain>4-Cl-phenyl </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>30.8 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>0.511 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>2e </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>3,4-(OH)2-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="440" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>71.2 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="442" pm="."><plain>0.148 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="443" pm="."><plain>2m </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="444" pm="."><plain>4-N(CH3)2-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="445" pm="."><plain>4-Cl-phenyl </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>20.6 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>0.686 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>2f </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>3-OCH3-4-OH-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="450" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>39.2 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="452" pm="."><plain>0.407 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="453" pm="."><plain>2n </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="454" pm="."><plain>4-OH-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="455" pm="."><plain>4-Cl-phenyl </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>3.4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>1.469 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>2g </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>2-OH-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="460" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>5.0 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="462" pm="."><plain>1.301 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="463" pm="."><plain>2o </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="464" pm="."><plain>2,5-(OCH3)2-phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="465" pm="."><plain>4-Cl-phenyl </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>0.1 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>2h </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>phenyl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="470" pm="."><plain>H </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>14.2 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="472" pm="."><plain>0.848 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text></text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text></text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td colspan="15" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="473" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>Cmp. </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>R1 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="476" pm="."><plain>R2 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="477" pm="."><plain>R3 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="478" pm="."><plain>% DPPH </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="479" pm="."><plain>pDPPH </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>3a </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>CH2COOH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="482" pm="."><plain>-CH3 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="483" pm="."><plain>-CH3 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" rowspan="1"><text><SENT sid="484" pm="."><plain>0.5 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" rowspan="1"><text><SENT sid="485" pm="."><plain>2.301 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>3b </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>CH2COOH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="488" pm="."><plain>-F </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="489" pm="."><plain>-CH3 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" rowspan="1"><text><SENT sid="490" pm="."><plain>0.4 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" rowspan="1"><text><SENT sid="491" pm="."><plain>2.398 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>3c </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>CH2COOH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="494" pm="."><plain>-OCH3 </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="495" pm="."><plain>-CH3 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" rowspan="1"><text><SENT sid="496" pm="."><plain>0.4 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" rowspan="1"><text><SENT sid="497" pm="."><plain>2.398 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>3d </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>CH2COOH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="500" pm="."><plain>-Cl </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="501" pm="."><plain>-CH3 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" rowspan="1"><text><SENT sid="502" pm="."><plain>0 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" rowspan="1"><text><SENT sid="503" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>3e </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>CH2COOH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="506" pm="."><plain>-Br </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" rowspan="1"><text><SENT sid="507" pm="."><plain>-CH3 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" rowspan="1"><text><SENT sid="508" pm="."><plain>2.4 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" rowspan="1"><text><SENT sid="509" pm="."><plain>1.62 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>3f </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>CH2COOH </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="512" pm="."><plain>-I </plain></SENT>
</text></td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="513" pm="."><plain>-CH3 </plain></SENT>
</text></td><td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="514" pm="."><plain>2.2 </plain></SENT>
</text></td><td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="515" pm="."><plain>1.658 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="molecules-23-01897-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-01897-t003_Table 3</object-id><label>Table 3</label><caption><p><text><SENT sid="516" pm="."><plain>Docking score and energy of the interactions between protein residue and ligand 2e. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>Complex </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>Total Energy/kcal·mol−1 </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>van der Waals Interaction </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>H Bond </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>Elec </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>2HCK + 2e </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>−77.1535 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>−53.5621 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>−23.5914 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>H Bond </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>Energy </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>van der Waals interaction </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>Energy </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>H-M-MET-341 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>−8.5 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>V-S-LEU-273 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>−8.07 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>H-M-SER-345 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>−3.5 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>V-S-VAL-281 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>−4.13 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>H-S-SER-345 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>−3.46 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>V-S-PHE-340 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>−4.79 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>H-S-ASP-348 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>−6.60 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>V-M-GLY-344 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>−5.96 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>V-M-SER-345 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>−5.28 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>V-S-LEU-393 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>−4.10 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></sec></back></article>
